Written by Kenji Takahashi
McGraw Hill’s October 1 announcement is modest in dollar size but meaningful in direction: the education-solutions company made an additional $50 million principal prepayment on its outstanding term loan. The official release says McGraw Hill has now prepaid $659 million of term-loan principal and $699 million of aggregate principal, including 2029 senior unsecured notes, since its July 2025 IPO. The catalyst is balance-sheet execution—not a buyback, acquisition or artificial-intelligence infrastructure story.
| ANALYTICAL LENS | CURRENT POSITION |
| Entity card | McGraw Hill, Inc. (MH), NYSE-listed common stock; fiscal year ends March 31; U.S. dollars, generally millions unless stated otherwise; education solutions across preK–12, higher education and professional learning. |
| Explicit verdict | Accumulate MH — the company is demonstrating debt-reduction intent, and a smaller balance-sheet burden can add equity value if it converts guidance into cash and reaches its stated leverage destination. |
| 12-month target | $15.50 per share, a fundamental constant-enterprise-value / target-net-debt framework, not management guidance or a consensus target. |
| Target calculation | At 6.342x implied EV / FY2027 EBITDA midpoint, $4.883bn enterprise value minus $1.925bn target net debt ÷ 191.276m shares = $15.47, rounded to $15.50. |
The current balance-sheet starting point comes from the latest official presentation, with information as of June 30. It reported $2.629 billion of gross debt, $194 million of cash, $2.435 billion of total net indebtedness and $760 million of LTM adjusted EBITDA, or 3.2x net leverage; revolvers were undrawn. Management reaffirmed its fiscal-2027 guide for $2.115–$2.175 billion of revenue and $750–$790 million of adjusted EBITDA. The $770 million midpoint is the earnings anchor used here.
There is an important mechanical distinction. A debt prepayment funded from existing cash lowers gross debt but does not necessarily lower net debt on the same day. The $50 million action is therefore evidence of capital-allocation direction, not an automatic $50 million gain in net-debt reduction. The investment case needs operating cash generation and additional balance-sheet actions to close the gap between June 30 net debt and the company’s stated 2.0x–2.5x net-leverage destination. Management has stated that range but has not committed to a date for reaching it.
The target begins with the official issuer price snapshot of $12.80, shown on the company’s quote page. It is a delayed/live issuer-provided snapshot with no visible timestamp in the retrieved page text, not a certified October 2 closing price. Using the 191.276 million shares outstanding reported in the June 30 10-Q, the indicated market capitalization is $2.4483 billion. Add $2.435 billion of June 30 net indebtedness and implied enterprise value is $4.8833 billion.
The calculation holds that implied enterprise value divided by the $770 million FY2027 adjusted-EBITDA midpoint constant: $4.8833 billion ÷ $770 million = 6.342x. It then assumes management reaches the upper bound of its own 2.0x–2.5x net-leverage range within 12 months. Target net debt equals 2.5 × $770 million = $1.925 billion. At unchanged enterprise value, target equity value is $4.8833 billion − $1.925 billion = $2.9583 billion. Dividing by 191.276 million shares produces $15.4663, rounded to $15.50.
That framework implies 20.8% upside from the $12.80 snapshot before dividends, but it deliberately does not assume a valuation re-rating, an undisclosed earnings forecast or a peer multiple. It does assume FY2027 adjusted EBITDA meets the official midpoint, the share count stays constant, the implied EV/EBITDA multiple is unchanged and the leverage objective is reached within a year. Any one of those can fail.
The major risks are visible in the calculation: adjusted EBITDA is non-GAAP; curriculum-adoption timing, cash conversion, interest expense, debt reduction and the delayed price input can all change. More fundamentally, the company’s stated leverage endpoint is not a twelve-month promise. The next earnings reports need to show that free cash flow is consistently reducing net debt, rather than merely reshaping gross debt and cash. That is why the verdict is Accumulate rather than an unqualified Buy.
